Methods and formulations for modulating the human sexual respons

Details Methods and formulations for modulating the human sexual respons Methods and formulations for modulating the human sexual respons

1997-10-29

1999-11-09

Spivack, Phyllis G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

A61K 31415

Patent

active

059815639

ABSTRACT:
The invention is directed to improved methods for modulating the human sexual response by orally administering a rapidly dissolving tablet comprising phentolamine or its pharmaceutically acceptable salts to the blood circulation, thereby modulating the sexual response on demand.

REFERENCES:
patent: 2503059 (1950-04-01), Miescher et al.
patent: 3937834 (1976-02-01), Hunger et al.
patent: 3943246 (1976-03-01), Sturmer
patent: 4127118 (1978-11-01), Latorre
patent: 4139617 (1979-02-01), Grunwell et al.
patent: 4530920 (1985-07-01), Nestor et al.
patent: 4801587 (1989-01-01), Voss et al.
patent: 4863911 (1989-09-01), Anderson, Jr. et al.
patent: 4885173 (1989-12-01), Stanley et al.
patent: 5059603 (1991-10-01), Rubin
patent: 5065744 (1991-11-01), Zusmanovsky
patent: 5079018 (1992-01-01), Ecanow
patent: 5145852 (1992-09-01), Virag
patent: 5236904 (1993-08-01), Gerstenberg et al.
patent: 5256652 (1993-10-01), El-Rashidy
patent: 5270323 (1993-12-01), Milne, Jr. et al.
patent: 5298261 (1994-03-01), Pebley et al.
patent: 5399581 (1995-03-01), Laragh et al.
patent: 5565466 (1996-10-01), Gioco et al.
patent: 5731339 (1998-03-01), Lowrey
ABPI Data Sheet Compendium, pp. 186-187 (1976).
ABPI Data Sheet Compendium, pp. 186-189 (1977).
Becker, A.J. et al., "Oral Phentolamine as Treatment for Erectile Dysfunction," The Journal of Urology, 159:1214-1216 (1998).
British Pharmaceutical Codex 1954, London, The Pharmaceutical Press, 17 Bloomsbury Square WC1, pp.572-575.
British Pharmaceutical Codex 1959, London, The Pharmaceutical Press, 17 Bloomsbury Square WC1, pp.562-565.
British Pharmaceutical Codex 1968, London, The Pharmaceutical Press, 17 Bloomsbury Square WC1, pp. xxiv-xxvii and 616-619.
British Pharmaceutical Codex 1973, London, The Pharmaceutical Press, 17 Bloomsbury Square WC1A 2NN, pp.373-374.
British Pharmaceutical Codex 1963, The Pharmaceutical Press 17 Bloomsbury Square London WC1, pp. 600-603.
British Pharmacopceia 1968, The Pharmaceutical Press 17 Bloomsbury Square London WC1, pp.758-761.
British Pharmacopceia 1973, London Her Majesty's Stationary Office 1973, p.364.
British Pharmacopceia 1980, Vol. I, London Her Majesty's Stationary Office 1980, p. 344.
British Pharmacopceia 1980, Vol. II, London Her Majesty's Stationary Office 1980 (see attached--one page).
British Pharmacopceia 1988, Vol. I, London Her Majesty's Stationary Office, pp. 434-435.
British Pharmacopceia 1988, Vol. II, London Her Majesty's Stationary Office, p. 835.
Dhar, S.K. et al., "Clinical managment of hypertensive emergenices," Heart Lung, 5(4):571-575 (Jul./Aug., 1976).
Finkbeiner, A.E. et al., "Uropharmacology XI. Adrenergic-Blocking Agents and Drugs Affecting Catecholamine Binding and Release," Urology, 8(6):693-700 (Jun., 1979).
French Pharmaceutical Compendium, p. 1178 (1969).
French Pharmaceutical Compendium, pp. 1704-1705 (1964).
French Pharmaceutical Compendium, pp. 1802-1803 (1965).
German Drug Compendium, pp. 1028-1029 (1969).
German Drug Compendium, pp. 1054-1055 (1971).
Johnson, B.F. et al., "A controlled trial of oxprenolol and oral phentolamine in the management of hypertension," In: Hypertension -its nature and treatment. Burley, D.M. et al., (eds.). An international symposium, Malta, 18th-21st Oct. 1974. Horsham England, CIBA Laboratories, pp.259-268 (1975).
Kersting, F. et al., "Clinical Pharmacology of Prazosin and Phentolamine in Patients with Heart Failure," J. Cardiovascular Pharmacology, 2(Suppl. 3):S373-S383 (1980).
McCleane, G.J., "Oral Phentolamine Mesylate in the treatment of Complex Regional Pain Syndrome," The Ulster Medical Journal, 65(1):87-88 (May, 1996).
Montorsi, F. et al., "Pharmacological Measurement of Erectile Dysfunction," Drugs, 50(3):465-479 (1995).
Parte I SpecialitA Medicinali E Riferimenti Ad Altri Reparti Secondo Ordine Alfabetica, Italian Drug Compendium (L'Infromatore Farmaceutico) p.1, 535, and 753 (1979).
Parte I SpecialitA Medicinali, Italian Drug Compendium (L'Infromatore Farmaceutico), p.1 and 551 (1975).
Parte I SpecialitA Medicinali, Italian Drug Compendium (L'Infromatore Farmaceutico), pp.3 and 486 (1969).
Saeed, M. et al., ".alpha.-Adrenoceptor Blockage by Phentolamine Causes .beta.-Adrenergic Vasodilation by Increased Catecholamine Release Due to Presynaptic .alpha.-Blockade," Journal of Cardiovascular Pharmacology, 4:44-52 (1982).
Sj0strand, N.O. et al., "Principle mechanisms controlling retraction and protrusion in rabbits," Acta Physiol. Scand., 106(2):199-241 (Jun., 1979).
Taylor, S.H., "Vasodilator Drugs in the Treatment of Heart Failure," J. Cardiovascular Pharmacology, 2(Suppl. 3):S407-S425 (1980).
The Pharmacopeia of the United States of America (The United States Pharmacopeia), Fifteenth Revision, U.S.P. XV, By authority of The United States Pharmaceutical Convention, Inc., meeting at Washington, D.C., May 9 and 10, 1950, Prepared by the Committee of Revision and published by the Board of Trustees, Official from Dec. 15, 1955, pp. 936-939 and 540-543.
The Merck Index, Eighth Edition, Merck & Co., Inc., New Jersey, USA, p.814 (1968).
The Merck Index, Ninth Edition, Merck & Co., Inc., New Jersey, USA, p. 945 (1976).
The Merck Index of Chemicals and Drugs, Seventh Edition, Merck & Co., Inc., New Jersey, USA, p.799 (1960).
The Merck Index, Tenth Edition, Merck & Co., Inc., New Jersey, USA, p.1047-1048 (1983).
The Merck Index, Fourth Edition, Merck & Co., Inc., New Jersey, U.S.A., P.392 (1930).
Von Hippel, F.A., "Solution to a Conservation Problem," Science, 281:1805-1806 (Sep. 1998).
AC-Di-Sol.RTM., Croscarmellose Sodium, NF (Accelerates DisSolution) (Product Description Brochure); FMC Corporation, Philadelphia, PA, pp. 1-9 (1988).
Althof et al., "Sexual, psychological, and marital impact of self-injection of papaverine and phentolamine: a long-term prospective study," J. Sex & Marital Ther., 17(2):101-112 (1991).
Azadzoi, K.M. et al., "Effects of Intracavernosal Trazadone Hydrochloride: Animal and Human Studies," J. Urology, 144(5):1277-1282 (Nov., 1990).
Barnett et al., "The Action of Reitine in Man with Special Reference to Its Adrenergic Blocking Action," Austrail Annals of Medicine, 1:109-119 (1952).
Beavo, J.A. et al., In: Advances in Second Messenger and Phosphoprotein Research, Greengard et al., (eds.), vol. 22, pp. 1-38 (1988).
Biotechnology Newswatch, "Nice try, but no Viagra, say experts reveiwing new potency pills," pp. 4-5 (Jun., 1998).
Brindley, G.S., "Cavernosal Alpha-Blockade: A New Technique for Investigating and Treating Erectile Impotence," Brit. J. Psychiat., 143:332-337 (1983).
Brindley, G.S., "Pilot experiments on the actions of drugs injected into the human corpus cavernosum penis," Br. J. Pharmac., 87:495-500 (1986).
Brindley, G.S., "Cavernosal alpha-blockage and human penile erection," J. Physiol., 342:24P (1983).
Corriere, J.N. Jr. et al., "Development of Fibrotic Penile Lesions Secondary to the Intracorporeal Injection of Vasoactive Agents," J. Urology, 140:615-617 (1988).
Dawson, A. et al., "The Transient Anti-Hypertensive Effect of Phentolamine in Patients Receiving Beta-Blocker Treatment," J. Int. Med. Res., 5:462-464 (1977).
Diedrichs, W., et al., "Reduction of Sympathetic Influence on Penile Erection by Phentolamine," Urol. Int., 46:64-66 (1991).
Georgopoulos, A.J., et al., "Treatment of Chronic Heart Failure with Slow Release Phentolaminee," Europ. J. Clin. Pharmacol., 13:325-329 (1978).
Gissinger, D. et al., "A Comparative Evaluation of the Properties of Some Tablet Disintegrants," Drug Development and Industrial Pharmacy, 6(5):511-536 (1980).
Godbillion et al., "Determination of the Major Metabolite of Phentolamine in Human Plasma And Urine By High-Performance Liquid Chromatography," J. Chromatography, 222:461-466 (1981).
Gould, L.A. et al., "Oral Therapy with Phetolamine in Chronic Congestive Heart Failure," Chest, 75(4):487-491 (Apr., 1979).
Gwinup, G., "Oral Phentolamine in Nonspecific Erectile Insufficiency," Ann. Int. Med., 109(2):162-163 (Jul., 1998).
Imhof, P.R. et al., "Human Pharmacology of Orally Administered Phentolamine," In: Phentolamine in Heart Failure and Other Cardiac Disorders, Taylor, S.H., and Goul

Affiliated with

Also associated with

Rating

Methods and formulations for modulating the human sexual respons does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and formulations for modulating the human sexual respons, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and formulations for modulating the human sexual respons will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1456537